Generation of MHC class I‐restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: antigen presentation by non‐muscle cells

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Immunology

• Publication date

  1996-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1046/j.1365-2567.1996.d01-718.xPMID 8911141PMCID PMC1456656
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Potential DNA Vaccine Integration into Host Cell Genome

  1995cited by this paper
• Cancer gene therapy using plasmid DNA: pharmacokinetic study of DNA following injection in mice.

  1995cited by this paper
• Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines.

  1995cited by this paper
• Fibroblasts as efficient antigen-presenting cells in lymphoid organs.

  1995cited by this paper
• CpG motifs in bacterial DNA trigger direct B-cell activation

  1995cited by this paper
• Protective Efficacy of Intramuscular Immunization with Naked DNA

  1995cited by this paper
• Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor.

  1994cited by this paper
• Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens.

  1994cited by this paper
• Induction of specific tolerance by intrathymic injection of recipient muscle cells transfected with donor class I major histocompatibility complex.

  1994cited by this paper
• Myoblasts fail to stimulate T cells but induce tolerance.

  1994cited by this paper
• Protective immunity by intramuscular injection of low doses of influenza virus DNA vaccines.

  1994cited by this paper
• Recombinant Retroviral Vector Delivered Intramuscularly Localizes to the Site of Injection in Mice

  1994cited by this paper
• Immunization with DNA.

  1994cited by this paper
• Prevention of T cell anergy by signaling through the gamma c chain of the IL-2 receptor.

  1994cited by this paper
• Direct Gene Transfer into Skeletal Muscle In Vivo: Factors Affecting Efficiency of Transfer and Stability of Expression

  1993cited by this paper
• Gene Therapy by Intramuscular Injection of Plasmid DNA: Studies on Firefly Luciferase Gene Expression in Mice

  1993cited by this paper
• Heterologous protection against influenza by injection of DNA encoding a viral protein.

  1993cited by this paper
• Characterization of antigen-presenting cells that present exogenous antigens in association with class I MHC molecules.

  1993cited by this paper
• Heterologous and Homologous Protection Against Influenza A by DNA Vaccination: Optimization of DNA Vectors

  1993cited by this paper
• Human myoblasts as antigen-presenting cells.

  1992cited by this paper
• Genetic immunization is a simple method for eliciting an immune response

  1992cited by this paper
• Expression of naked plasmids by cultured myotubes and entry of plasmids into T tubules and caveolae of mammalian skeletal muscle.

  1992cited by this paper
• Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle.

  1992cited by this paper
• Systemic delivery of recombinant proteins by genetically modified myoblasts.

  1991cited by this paper
• Direct gene transfer into mouse muscle in vivo.

  1990cited by this paper
• Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection

  1990cited by this paper
• Characterization and immunological properties of influenza A virus nucleoprotein (NP): cell-associated NP isolated from infected cells or viral NP expressed by vaccinia recombinant virus do not confer protection.

  1990cited by this paper
• Elevated MHC class I and II antigens in cultured human embryonic myoblasts following stimulation with γ‐interferon

  1990cited by this paper
• T cell memory is short-lived in the absence of antigen

  1988cited by this paper
• Expression of immunoreactive major histocompatibility complex products in human skeletal muscles

  1988cited by this paper
• Purified influenza virus nucleoprotein protects mice from lethal infection.

  1987cited by this paper
• Growth of neonatal hamster skeletal muscle in culture

  1981cited by this paper

• Multifaceted arsenal in SELEX nanomedicine.

  2025cites this paper
• Pathways of MHC I cross-presentation of exogenous antigens.

  2023cites this paper
• New vector and vaccine platforms: mRNA, DNA, viral vectors

  2022cites this paper
• Zika virus vaccines

  2018cites this paper
• Self-Crosslinking Lipopeptide/DNA/PEGylated Particles: A New Platform for DNA Vaccination Designed for Assembly in Aqueous Solution

  2018cites this paper
• Development and immune correlates of Zika virus vaccines

  2018cites this paper
• FUSION PROTEINS AN IMMUNE RESPONSE

  2017cites this paper
• IMMUNOGENICITY OF pALPHA RECOMBINANT PLASMID ENCODING RABIES VIRULENT VIRUS GLYCOPROTEIN GENE

  2016cites this paper
• Estudio de terapias antígeno-específicas para la prevención de la diabetes tipo 1 en el ratón nod

  2016cites this paper
• Cancer vaccines

  2015cites this paper
• Active immunization in population

  2015cites this paper
• Respiratory Virus Vaccines

  2015cites this paper
• Development and assessment of novel vaccination strategies for hepatitis B virus infection.

  2014cites this paper
• Presentation via Class II MHC Vaccination: Dependence on Antigen Cytotoxic T Cell Responses to DNA

  2013cites this paper
• DNA vaccines: roles against diseases.

  2013cites this paper
• Cross-Protective Immune Responses Elicited by Live Attenuated Influenza Vaccines

  2013cites this paper
• Epitope-driven DNA vaccine design employing immunoinformatics against B-cell lymphoma: a biotech's challenge.

  2012cites this paper
• Preclinical development of DNA vaccine candidates for the treatment of HPV16 induced malignancies

  2012cites this paper
• DNA vaccines and intradermal vaccination by DNA tattooing.

  2012cites this paper
• Polymer-mediated DNA vaccine delivery via bystander cells requires a proper balance between transfection efficiency and cytotoxicity.

  2012cites this paper
• Intradermal Immunization

  2012cites this paper
• Transgene expression and local tissue distribution of naked and polymer-condensed plasmid DNA after intradermal administration in mice.

  2012cites this paper
• Identification of HLA-A24-restricted CD8(+) cytotoxic T-cell epitopes derived from mammaglobin-A, a human breast cancer-associated antigen.

  2012cites this paper
• Improving Polymer-Mediated DNA Vaccine Delivery

  2011cites this paper
• Experimental DNA vaccine against filariasis

  2011cites this paper
• Induction of Virus-Specific Cytotoxic T Lymphocytes as a Basis for the Development of Broadly Protective Influenza Vaccines

  2011cites this paper
• Progress Towards a Needle-Free Hepatitis B Vaccine

  2011cites this paper
• Dendritic Cells Transfected with scFv from Mab 7.B12 Mimicking Original Antigen gp43 Induces Protection against Experimental Paracoccidioidomycosis

  2011cites this paper
• Applications of Gene Therapy

  2011cites this paper
• Cancer Immunotherapy and Nanomedicine

  2011cites this paper
• ACTIVE IMMUNIZATION IN POPULATION

  2010cites this paper
• Naked DNA Vaccines

  2010cites this paper
• Herpes simplex virus oncolytic vaccine therapy in melanoma

  2010influential citation
• FDA guidance on prophylactic DNA vaccines: analysis and recommendations.

  2010cites this paper
• DNA vaccination in oncology: current status, opportunities and perspectives.

  2010cites this paper
• Rabies DNA vaccine encoding lysosome‐targeted glycoprotein supplemented with Emulsigen‐D confers complete protection in preexposure and postexposure studies in BALB/c mice

  2010cites this paper
• Biosafety of DNA vaccines: New generation of DNA vectors and current knowledge on the fate of plasmids after injection.

  2010cites this paper
• DNA Vaccination: Using the Patient's Immune System to Overcome Cancer

  2010cites this paper
• Bridging Innate and Adaptive Antitumor Immunity Targeting Glycans

  2010cites this paper
• Duchenne muscular dystrophy and extraocular muscle: a potential sparing mechanism with therapeutic implications.

  2009cites this paper
• DNA vaccines against influenza viruses.

  2009cites this paper
• Transcutaneous immunization by lipoplex-patch based DNA vaccines is effective vaccination against Japanese encephalitis virus infection.

  2009cites this paper
• Formulation and delivery of dermal DNA vaccines

  2009cites this paper
• Transdermal immunization with low-pressure-gene-gun mediated chitosan-based DNA vaccines against Japanese encephalitis virus.

  2009cites this paper
• Synthetic vehicles for DNA vaccination

  2009cites this paper
• Strategies to modulate immune responses: a new frontier for gene therapy.

  2009cites this paper
• The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells.

  2008cites this paper
• Regulating the regulators: Using CD25 depletion to enhance immune responses to a model plasmid-based vaccine

  2008cites this paper
• Comparative study on the immunogenicity between Hsp70 DNA vaccine and Hsp65 DNA vaccine in humanMycobacterium tuberculosis

  2008cites this paper
• A DNA vaccine against tuberculosis based on the 65 kDa heat-shock protein differentially activates human macrophages and dendritic cells

  2008cites this paper
• Influenza virus-specific cytotoxic T lymphocytes: a correlate of protection and a basis for vaccine development.

  2007cites this paper
• Optimization of an FaeG DNA vaccine in pigs

  2007cites this paper
• DNA vaccines: are they still just a powerful tool for the future?

  2007cites this paper
• AVALIAÇÃO DA RESPOSTA IMUNE A VACINAS DE ANTÍGENO PARTICULADO DE Leishmania sp E SUA ASSOCIAÇÃO COM VACINA DE DNA pCI-neo-p36(LACK) EM CAMUNDONGOS BALB/c DESAFIADOS COM Leishmania chagasi

  2007cites this paper
• Immunotherapy of melanoma: a critical review of current concepts and future strategies

  2007cites this paper
• Potential of Transfected Muscle Cells to Contribute to DNA Vaccine Immunogenicity1

  2007cites this paper
• HIV-1 DNA vaccine efficacy is enhanced by coadministration with plasmid encoding IFN-alpha.

  2007cites this paper
• Las vacunas de ADN: una promisoria medicina para el paciente veterinario

  2006cites this paper
• Molecular and immunogenic analysis of Jembrana disease virus Tat

  2006cites this paper
• Evaluation of different plasmid DNA delivery systems for immunization against HER2/neu in a transgenic murine model of mammary carcinoma.

  2006cites this paper
• Delivery of DNA vaccines against cancer

  2006cites this paper
• From Plasmids to Protection: A Review of DNA Vaccines Against Infectious Diseases

  2006cites this paper
• Immune Enhancement Mechanisms by the Complement Protein C3d

  2006cites this paper
• Molecular chaperones and cancer immunotherapy.

  2006cites this paper
• DNA vaccination: a simple concept with challenges regarding implementation.

  2006cites this paper
• In vivo effects of oligodeoxynucleotides containing synthetic immunostimulatory motifs in weaned piglets.

  2006cites this paper
• A stress protein-facilitated antigen expression system for plasmid DNA vaccines.

  2006cites this paper
• Editorial: DNA Vaccination: A Simple Concept with Challenges Regarding Implementation

  2006cites this paper
• Field trials of a very potent rabies DNA vaccine which induced long lasting virus neutralizing antibodies and protection in dogs in experimental conditions.

  2006cites this paper
• Vaccine development strategies applied to the Plasmodium falciparum malaria antigen 332

  2006cites this paper
• Human clinical trials of plasmid DNA vaccines.

  2005cites this paper
• Transfection of baboon dendritic cells with plasmid DNA containing HIV-1C genes : effect of transfection methods on antigen processing and presentation to T lymphocytes

  2005cites this paper
• DNA vaccination in immunotherapy of cancer.

  2005cites this paper
• Development and characterization of the immune response induced by peptides and DNA constructs that mimic the capsular polysaccharide of Neisseria meningitidis serogroup C

  2005cites this paper
• DNA Vaccination against Autoimmune Diseases

  2005cites this paper
• Time course study of in situ expression of antigens following DNA-vaccination against VHS in rainbow trout (Oncorhynchus mykiss Walbaum) fry.

  2005cites this paper
• In vivo induction of cellular and humoral immune responses by hybrid DNA vectors encoding simian/human immunodeficiency virus/hepatitis B surface antigen virus particles in BALB/c and HLA-A2-transgenic mice.

  2005cites this paper
• DNA vaccines for poultry: the jump from theory to practice

  2005cites this paper
• Immunization with a bovine herpesvirus 1 glycoprotein B DNA vaccine induces cytotoxic T-lymphocyte responses in mice and cattle.

  2005cites this paper
• DNA vaccination against tumors

  2005cites this paper
• Antigen Expression Kinetics and Immune Responses of Mice Immunized with Noninfectious Simian-Human Immunodeficiency Virus DNA

  2005cites this paper
• DNA Vaccine

  2005influential citation
• Ag85B of Mycobacteria Elicits Effective CTL Responses through Activation of Robust Th1 Immunity as a Novel Adjuvant in DNA Vaccine1

  2005cites this paper
• Protection against Atlantic halibut nodavirus in turbot is induced by recombinant capsid protein vaccination but not following DNA vaccination.

  2005cites this paper
• VaccineImmunity as a Novel Adjuvant in DNA Responses through Activation of Robust Th1 Ag85B of Mycobacteria Elicits Effective CTL

  2005cites this paper
• Enhanced Potency of Plasmid DNA Microparticle Human Immunodeficiency Virus Vaccines in Rhesus Macaques by Using a Priming-Boosting Regimen with Recombinant Proteins

  2005cites this paper
• Exploring the potential of novel multivalent DNA-based vaccines

  2005cites this paper
• Nonviral delivery of cancer genetic vaccines.

  2005cites this paper
• Construction, Characterization and Immunogenicity of Human Immunodeficiency Virus-Like Particles

  2005cites this paper
• Microparticles for the delivery of DNA vaccines

  2004cites this paper
• DNA Vaccines against Human Immunodeficiency Virus Type 1 in the Past Decade

  2004cites this paper
• Development of vaccines and experimental models for chronic infections caused by the hepatitis C virus

  2004cites this paper
• Comparison of DNA delivery systems for vaccination against intracellular bacteria

  2004cites this paper
• CD80 and CD86, but not CD154, augment DNA vaccine-induced protection in experimental bovine tuberculosis.

  2004cites this paper
• DNA vaccines against human immunodeficiency virus type 1

  2004cites this paper
• Influence of polypeptide size and intracellular sorting on the induction of epitope-specific CTL responses by DNA vaccines in a mouse model.

  2004cites this paper
• DNA vaccines for allergy treatment.

  2004cites this paper
• DNA vaccines expressing antigens with a stress protein‐capturing domain display enhanced immunogenicity

  2004cites this paper
• Secretory heat-shock protein as a dendritic cell-targeting molecule: a new strategy to enhance the potency of genetic vaccines

  2004cites this paper
• Analysis of P97 and P102 paralogs of Mycoplasma hyopneumoniae

  2004cites this paper